Dye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Biodistribution analyses of nanocarriers are often performed with optical imaging. Though dye tags can interact with transporters, e.g., organic anion transporting polypeptides (OATPs), their influence on biodistribution was hardly studied. Therefore, this study compared tumor cell uptake and biodistribution (in A431 tumor-bearing mice) of four near-infrared fluorescent dyes (AF750, IRDye750, Cy7, DY-750) and dye-labeled poly(N-(2-hydroxypropyl)methacrylamide)-based nanocarriers (dye-pHPMAs). Tumor cell uptake of hydrophobic dyes (Cy7, DY-750) was higher than that of hydrophilic dyes (AF750, IRDye750), and was actively mediated but not related to OATPs. Free dyes' elimination depended on their hydrophobicity, and tumor uptake correlated with blood circulation times. Dye-pHPMAs circulated longer and accumulated stronger in tumors than free dyes. Dye labeling significantly influenced nanocarriers' tumor accumulation and biodistribution. Therefore, low-interference dyes and further exploration of dye tags are required to achieve the most unbiased results possible. In our assessment, AF750 and IRDye750 best qualified for labeling hydrophilic nanocarriers.

Cite

CITATION STYLE

APA

Schraven, S., Rosenhain, S., Brueck, R., Wiechmann, T. M., Pola, R., Etrych, T., … Kiessling, F. (2023). Dye labeling for optical imaging biases drug carriers’ biodistribution and tumor uptake. Nanomedicine: Nanotechnology, Biology, and Medicine, 48. https://doi.org/10.1016/j.nano.2023.102650

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free